Contract manufacturer Boehringer Ingelheim has formally taken ownership of the Fremont, CA, biopharma development and manufacturing facility of long-time client Amgen. The 200,000 square feet of lab, manufacturing and process development space represents a fully integrated site, which complements the CMO's sites in Biberach, Germany, and Vienna, Austria. The site is the work home of 300 employees. Announcement